Rapiclav 250 mg+62.5 mg (Tablet)
Unit Price: ৳ 30.00 (2 x 6: ৳ 360.00)
Strip Price: ৳ 180.00
Medicine Details
Category | Details |
---|---|
Generic | Cefuroxime axetil clavulanic acid |
Company | Techno drugs ltd |
Also available as |
Title
- Rapiclav 250 mg Tablet
Categories
- Medicines
- Antibiotics
- Cephalosporins
- Infectious Diseases
Description
- Rapiclav 250 mg Tablet is indicated for the treatment of infections caused by sensitive bacteria.
Strength
- 250 mg
Formulation
- Tablet
Pharmacology
- Bactericidal second-generation cephalosporin antibiotic
- Active against a wide range of Gram-positive and Gram-negative susceptible organisms
- Inhibits bacterial cell wall synthesis by interfering with the transpeptidation process
- Clavulanic acid is a beta-lactamase inhibitor produced by Streptomyces clavuligerus
- Protects Cefuroxime from degradation by beta-lactamase enzymes
- Provides a solution for the treatment of bacterial infections caused by beta-lactam-resistant bacteria
Dosage and Administration
- Adults: 250-500 mg twice daily for various durations depending on the type of infection
- Paediatric Patients (3 months to 12 years): 20-30 mg/kg/day twice daily for different durations based on the condition
Interaction
- Probenecid may increase the area under the serum concentration versus time curve by 50%
- Drugs that reduce gastric acidity may result in lower bioavailability of Cefuroxime
- Potential cancellation of postprandial absorption effects
Contraindications
- Known allergy to cephalosporin
- Pseudomembranous Colitis
Side Effects
- Nausea
- Vomiting
- Diarrhea
- Abdominal discomfort or pain
- Possible overgrowth of nonsusceptible microorganisms with prolonged administration
- Rarely: renal dysfunction, anaphylaxis, angioedema, pruritis, rash, serum sickness like urticaria
Pregnancy and Lactation
- Avoid in the first trimester if possible
- Safe to use in later pregnancy for treating urinary and other infections
- Excreted into breast milk in small quantities, caution advisable to avoid sensitizing the infant
Precautions and Warnings
- Given with care to patients receiving concurrent treatment with potent diuretics
- Caution in patients with a history of colitis
Therapeutic Class
- Second generation Cephalosporins
Storage Conditions
- Store in a cool, dry place (below 30°C)
- Away from light and moisture
- Keep out of the reach of children
Indications
- Pharyngitis/Tonsillitis caused by Streptococcus pyogenes
- Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes
- Acute bacterial maxillary sinusitis
- Lower respiratory tract infections including pneumonia
- Uncomplicated skin and skin-structure infections
- Uncomplicated urinary tract infections
- Bone and Joint Infections
- Uncomplicated Gonorrhoea
- Early Lyme Disease (erythema migrans)
- Septicemia
- Meningitis
- Switch therapy
Commonly Asked Questions
- What is Rapiclav 250 mg Tablet?
- What is Rapiclav 250 mg Tablet used for?
- How long does it take for Rapiclav 250 mg Tablet to take effect?
- How long do the effects of this medicine last?
- Is it safe to consume alcohol while taking this medicine?
- Is it a habit-forming medicine?
- Can it be taken during pregnancy?
- Can it be taken while breast-feeding?
- Quick Tips
Usability Features
- Well-tolerated
- Effect starts within 2-3 hours after taking
- Effect lasts for an average duration of 4-8 hours
- Can be taken without regard to food
Technical Specifications
- 250 mg strength
- Bactericidal action
- Interferes with transpeptidation process
- Beta-lactamase inhibitor
- Excreted into breast milk in small quantities
Design Elements
- Tablet form
- Potential cancellation of postprandial absorption effects
Related Brands
- Cefurav Plus (125 mg+31.25 mg)/5 ml (Powder for Suspension) - team-pharmaceuticals-ltd
- Cefurav Plus 500 mg+125 mg (Tablet) - team-pharmaceuticals-ltd
- Cefurav Plus 250 mg+62.5 mg (Tablet) - team-pharmaceuticals-ltd
- Roxiclav 250 mg+62.5 mg (Tablet) - euro-pharma-ltd
- Roxilab Plus (125 mg+31.25 mg)/5 ml (Powder for Suspension) - labaid-pharma-ltd